Update on docetaxel patent infringement case

TAC has been admitted as Amicus Curiae in the docetaxel patent challenge between Cipla and Aventis. The case will be heard in the Supreme Court of Appeal in Bloemfontein, Free State on 15 May 2012.  Today SECTION27 filed the Heads of Argument on behalf of TAC which can be accessed here

Leave a Reply

Your email address will not be published. Required fields are marked *